Literature DB >> 33716216

Innate and adaptive immune cells in Tumor microenvironment.

Shrihari T G1.   

Abstract

Innate and adaptive immune cells recruited to the tumor microenvironment by chemokines following noxious stimuli such as physical or chemical or infectious agents. Innate and adaptive immune cells release inflammatory mediators such as cytokines, chemokines, growth factors, proteolytic enzymes, activate transcription factors (NF-KB, STAT3,HIF-1a) results in tumor initiation, promotion, and progression. This article highlights about the role of innate and adaptive immune cells in tumor microenvironment.

Entities:  

Year:  2021        PMID: 33716216

Source DB:  PubMed          Journal:  Gulf J Oncolog        ISSN: 2078-2101


  7 in total

Review 1.  Emerging micro-nanotechnologies for extracellular vesicles in immuno-oncology: from target specific isolations to immunomodulation.

Authors:  Nna-Emeka Onukwugha; Yoon-Tae Kang; Sunitha Nagrath
Journal:  Lab Chip       Date:  2022-09-13       Impact factor: 7.517

2.  Hsa_circ_0046523 Mediates an Immunosuppressive Tumor Microenvironment by Regulating MiR-148a-3p/PD-L1 Axis in Pancreatic Cancer.

Authors:  Xiaowei Fu; Gen Sun; Shuju Tu; Kang Fang; Yuanpeng Xiong; Yi Tu; Ming Zha; Tao Xiao; Weidong Xiao
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

3.  An Immune Feature-Based, Three-Gene Scoring System for Prognostic Prediction of Head-and-Neck Squamous Cell Carcinoma.

Authors:  Yamin Zhang; Xiayan Luo; Jing Yu; Kejia Qian; Huiyong Zhu
Journal:  Front Oncol       Date:  2022-01-11       Impact factor: 6.244

4.  Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy.

Authors:  Yunqiang Liu; Mengjun Tu; Lingling Wang
Journal:  Int J Gen Med       Date:  2022-02-25

5.  Landscape of Infiltrated Immune Cell Characterization in Uveal Melanoma to Improve Immune Checkpoint Blockade Therapy.

Authors:  Xiaohui Lv; Min Ding; Yan Liu
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

Review 6.  Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications.

Authors:  Pinhao Fang; Jianfeng Zhou; Zhiwen Liang; Yushang Yang; Siyuan Luan; Xin Xiao; Xiaokun Li; Hanlu Zhang; Qixin Shang; Xiaoxi Zeng; Yong Yuan
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

Review 7.  The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer.

Authors:  Nina Jiang; Ye Hu; Meiling Wang; Zuowei Zhao; Man Li
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.